Note 5 - Significant Risks and Uncertainties	6 Months Ended
Dec. 31, 2022
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	*Note 5. Significant Risks and Uncertainties* *(a) Major Customers.* In the three months ended December 31, 2022 and 2021, approximately 91% and 90%, respectively, of consolidated net sales were derived from two customers. These two customers are in the Company’s Contract Manufacturing Segment and represented approximately 70% and 25% and 73% and 21% in the three months ended December 31, 2022 and 2021, respectively of the Contract Manufacturing Segment net sales. In the six months ended December 31, 2022 and 2021, approximately 88% and 90% of consolidated net sales, respectively, were derived from the same two customers and net sales to these two customers represented approximately 66% and 27% in the six months ended December 31, 2022 and 69% and 25% of net sales in the six months ended December 31, 2021, respectively of the Contract Manufacturing Segment net sales. Accounts receivable from these two major customers represented approximately 87% and 70% of total net accounts receivable as of December 31 and June 30, 2022, respectively. Two other customers in the other Nutraceutical Segment, while not significant customers of the Company’s consolidated net sales, represented approximately 81% and 1% and 34% and 23% of net sales of the Other Nutraceutical Segment in the three months ended December 31, 2022 and 2021, and 66% and 15% and 23% and 27%, of net sales of the Other Nutraceutical Segment in the six months ended December 31, 2022 and 2021, respectively. The loss of any of these customers could have an adverse effect on the Company’s operations. Major customers are those customers who account for more than 10% of net sales. *(b) Other Business Risks.* Approximately 75% of the Company’s employees are covered by a union contract and are employed in its New Jersey facilities. The contract was renewed effective September 1, 2022 and will expire on August 31, 2026. The Company is still experiencing supply chain disruptions relating to fuel refinery and transportation issues as it pertains to both shipping and production of plastics. These issues first arose as result of the COVID-19 pandemic and other geo-political events. This continues to impact the supply and demand of bottles and caps, key components in the Company's Contract Manufacturing Segment. Transportation, in general, continues to be an issue in the delay of receiving other raw materials and the Company's ability to meet promised delivery dates to the Company's customers in the Contract Manufacturing Segment. Additionally, the significant outbreak of this contagious disease in the human population has resulted in a widespread health crisis that could adversely affect the economies and financial markets of many countries, resulting in an economic downturn that could affect demand for the Company’s products and impact the Company’s operating results. While the Company hasn’t, to date, seen a significant negative impact in its margins resulting from the coronavirus outbreak, it is experiencing a negative impact on its margins due to inflation and tightened labor markets. During the first quarter of calendar 2022, the war in Ukraine affected the Company’s customer’s business operations in Ukraine and Russia, resulting in the cancelation of some future orders. The war resulted in the imposition of sanctions by the United States, the United Kingdom, and the European Union, that affect the cross-border operations of businesses operating in Russia. In addition, many multinational companies ceased or suspended their operations in Russia. Therefore, the ability to continue operations in Russia by the Company’s customers is uncertain. Also, there may be a shortage of Sunflower Oil products in the near future and this may cause delays in production of certain raw materials and may require reformulation of products. Additionally, unrelated to the war, a recent export ban of palm oil products from Indonesia may play a role in reformulation of many products. This may cause delays in finished products as these items will need to be reformulated and labels updated and printed with the changes, which may cause further delays.

Note 5 - Significant Risks and Uncertainties

6 Months Ended

Dec. 31, 2022

Concentration Risk Disclosure [Text Block]

Note 5. Significant Risks and Uncertainties

(a) Major Customers. In the three months ended December 31, 2022 and 2021, approximately 91% and 90%, respectively, of consolidated net sales were derived from two customers. These two customers are in the Company’s Contract Manufacturing Segment and represented approximately 70% and 25% and 73% and 21% in the three months ended December 31, 2022 and 2021, respectively of the Contract Manufacturing Segment net sales. In the six months ended December 31, 2022 and 2021, approximately 88% and 90% of consolidated net sales, respectively, were derived from the same two customers and net sales to these two customers represented approximately 66% and 27% in the six months ended December 31, 2022 and 69% and 25% of net sales in the six months ended December 31, 2021, respectively of the Contract Manufacturing Segment net sales. Accounts receivable from these two major customers represented approximately 87% and 70% of total net accounts receivable as of December 31 and June 30, 2022, respectively. Two other customers in the other Nutraceutical Segment, while not significant customers of the Company’s consolidated net sales, represented approximately 81% and 1% and 34% and 23% of net sales of the Other Nutraceutical Segment in the three months ended December 31, 2022 and 2021, and 66% and 15% and 23% and 27%, of net sales of the Other Nutraceutical Segment in the six months ended December 31, 2022 and 2021, respectively.

The loss of any of these customers could have an adverse effect on the Company’s operations. Major customers are those customers who account for more than 10% of net sales.

(b) Other Business Risks. Approximately 75% of the Company’s employees are covered by a union contract and are employed in its New Jersey facilities. The contract was renewed effective September 1, 2022 and will expire on August 31, 2026.

The Company is still experiencing supply chain disruptions relating to fuel refinery and transportation issues as it pertains to both shipping and production of plastics. These issues first arose as result of the COVID-19 pandemic and other geo-political events. This continues to impact the supply and demand of bottles and caps, key components in the Company's Contract Manufacturing Segment. Transportation, in general, continues to be an issue in the delay of receiving other raw materials and the Company's ability to meet promised delivery dates to the Company's customers in the Contract Manufacturing Segment.

Additionally, the significant outbreak of this contagious disease in the human population has resulted in a widespread health crisis that could adversely affect the economies and financial markets of many countries, resulting in an economic downturn that could affect demand for the Company’s products and impact the Company’s operating results.

While the Company hasn’t, to date, seen a significant negative impact in its margins resulting from the coronavirus outbreak, it is experiencing a negative impact on its margins due to inflation and tightened labor markets.

During the first quarter of calendar 2022, the war in Ukraine affected the Company’s customer’s business operations in Ukraine and Russia, resulting in the cancelation of some future orders. The war resulted in the imposition of sanctions by the United States, the United Kingdom, and the European Union, that affect the cross-border operations of businesses operating in Russia. In addition, many multinational companies ceased or suspended their operations in Russia. Therefore, the ability to continue operations in Russia by the Company’s customers is uncertain. Also, there may be a shortage of Sunflower Oil products in the near future and this may cause delays in production of certain raw materials and may require reformulation of products.

Additionally, unrelated to the war, a recent export ban of palm oil products from Indonesia may play a role in reformulation of many products. This may cause delays in finished products as these items will need to be reformulated and labels updated and printed with the changes, which may cause further delays.